JPWO2022060488A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022060488A5 JPWO2022060488A5 JP2023517698A JP2023517698A JPWO2022060488A5 JP WO2022060488 A5 JPWO2022060488 A5 JP WO2022060488A5 JP 2023517698 A JP2023517698 A JP 2023517698A JP 2023517698 A JP2023517698 A JP 2023517698A JP WO2022060488 A5 JPWO2022060488 A5 JP WO2022060488A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- composition
- seq
- peptide
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063080619P | 2020-09-18 | 2020-09-18 | |
| US63/080,619 | 2020-09-18 | ||
| PCT/US2021/045058 WO2022060488A1 (en) | 2020-09-18 | 2021-08-06 | Multiepitope vaccine for the treatment of alzheimer's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023541670A JP2023541670A (ja) | 2023-10-03 |
| JP2023541670A5 JP2023541670A5 (https=) | 2025-08-19 |
| JPWO2022060488A5 true JPWO2022060488A5 (https=) | 2025-08-19 |
Family
ID=80777125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517698A Pending JP2023541670A (ja) | 2020-09-18 | 2021-08-06 | アルツハイマー病の処置のためのマルチエピトープワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230355729A1 (https=) |
| EP (1) | EP4213941A4 (https=) |
| JP (1) | JP2023541670A (https=) |
| KR (1) | KR20230087499A (https=) |
| CN (1) | CN116438191A (https=) |
| AR (1) | AR123187A1 (https=) |
| AU (1) | AU2021345483A1 (https=) |
| CA (1) | CA3192387A1 (https=) |
| IL (1) | IL301262A (https=) |
| MX (1) | MX2023003008A (https=) |
| TW (1) | TW202227464A (https=) |
| WO (1) | WO2022060488A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| JP2025507875A (ja) | 2022-02-28 | 2025-03-21 | トライデム バイオサイエンス ゲーエムベーハー ウント コンパニー カーゲー | 少なくともβ－グルカン若しくはマンナンからなるか、又はこれを含む結合体 |
| WO2023161528A1 (en) | 2022-02-28 | 2023-08-31 | Tridem Bioscience Gmbh & Co Kg | A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4125784B2 (ja) * | 1995-10-20 | 2008-07-30 | ユニバーシティ・オブ・ネブラスカ・ボード・オブ・リージェンツ | 抗原提示細胞により仲介される免疫応答を高めるための組成物および方法 |
| US6632934B1 (en) * | 1998-09-30 | 2003-10-14 | Board Of Regents, The University Of Texas System | MORC gene compositions and methods of use |
| CA2885924C (en) * | 2012-08-21 | 2022-12-13 | Institute For Molecular Medicine, Inc. | Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein |
| UA118441C2 (uk) * | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
| JP6744856B2 (ja) * | 2014-04-08 | 2020-08-19 | プロセナ・バイオサイエンシズ・リミテッド | α−シヌクレインを認識する抗体を含む血液脳関門シャトル |
| US10745456B2 (en) * | 2015-04-01 | 2020-08-18 | The Scripps Research Institute | Methods and compositions related to GPCR agonist polypeptides |
| JP2023507949A (ja) * | 2019-12-30 | 2023-02-28 | スマート リキッド クリスタル テクノロジーズ カンパニー リミテッド | 感熱発色型液晶マイクロカプセル及びその製造方法、並びに感熱発色型容器 |
| WO2021236809A2 (en) * | 2020-05-19 | 2021-11-25 | Othair Prothena Limited | Multi-epitope vaccine for the treatment of alzheimer's disease |
| KR20230080397A (ko) * | 2020-08-07 | 2023-06-07 | 오타이르 프로테나 리미티드 | 알츠하이머 질환을 치료하기 위한 멀티에피토프 백신 |
-
2021
- 2021-08-06 IL IL301262A patent/IL301262A/en unknown
- 2021-08-06 EP EP21869944.5A patent/EP4213941A4/en active Pending
- 2021-08-06 CA CA3192387A patent/CA3192387A1/en active Pending
- 2021-08-06 KR KR1020237012950A patent/KR20230087499A/ko active Pending
- 2021-08-06 AU AU2021345483A patent/AU2021345483A1/en active Pending
- 2021-08-06 WO PCT/US2021/045058 patent/WO2022060488A1/en not_active Ceased
- 2021-08-06 MX MX2023003008A patent/MX2023003008A/es unknown
- 2021-08-06 US US18/245,532 patent/US20230355729A1/en active Pending
- 2021-08-06 JP JP2023517698A patent/JP2023541670A/ja active Pending
- 2021-08-06 CN CN202180064030.7A patent/CN116438191A/zh active Pending
- 2021-08-09 TW TW110129344A patent/TW202227464A/zh unknown
- 2021-08-09 AR ARP210102218A patent/AR123187A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI355390B (en) | Immunogenic peptide carrier conjugates and methods | |
| Valmori et al. | Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination | |
| US10596238B2 (en) | Methods and compositions related to immunogenic fibrils | |
| JP2002528515A (ja) | 多成分髄膜炎菌ワクチン | |
| JPH0674210B2 (ja) | 抗原の免疫原性の増強 | |
| US9849174B2 (en) | Methods and compositions related to immunogenic fibrils | |
| JP4063879B2 (ja) | 所望の決定基に対する免疫応答の誘導 | |
| CA2596730A1 (en) | Adjuvanting material comprising pam2cys or pam3cys covalently linked to a metal chelating group | |
| US20030175285A1 (en) | Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid | |
| JPWO2021236809A5 (https=) | ||
| US20050049197A1 (en) | Induction of immune response against desired determinants | |
| JPH05505188A (ja) | 合成ポリペプチド | |
| JP3057748B2 (ja) | 細胞毒性ｔリンパ球の特異的誘導用合成ワクチン | |
| JPWO2022060488A5 (https=) | ||
| JPWO2022032166A5 (https=) | ||
| EP0289110A2 (en) | Conjugate malaria vaccine | |
| JPWO2022060424A5 (https=) | ||
| EP0912195B1 (en) | Vaccine comprising antigens bound to carriers through labile bonds | |
| KR100887591B1 (ko) | 특정의 교차 반응성을 증가시키는 항원성 구조들의 제조방법 | |
| CA2363118A1 (en) | Immunogens comprising a peptide and a carrier derived from h.influenzae protein d | |
| JPWO2022060487A5 (https=) | ||
| JPWO2022031342A5 (https=) | ||
| CA2696068A1 (en) | Compositions and methods for the treatment and prophylaxis of hypertension | |
| WO2000074716A2 (en) | Ige peptides for allergy immunotherapy | |
| JP2004509846A (ja) | 肝炎ｃ型ウイルスコンジュゲート |